Analysis of Same Selected Immunomodulatory Properties of Chorionic Mesenchymal Stem Cells
Open Access
- 17 December 2020
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 10 (24) , 9040
Abstract
Mesenchymal stem cells (MSCs) represent a population of adherent cells that can be isolated from multiple adult tissues. MSCs have immunomodulatory capacity and the ability to differentiate into many cell lines. Research study examines the immunomodulatory properties of MSCs isolated from chorion (CMSCs). Following the stimulation process, it was found that MSCs are capable of immunomodulatory action via the release of bioactive molecules as well as through direct contact with the immune cells. Immunomodulatory potential of the CMSCs was analyzed by modifying proliferative capacity of mitogen-activated lymphocytes. CMSCs and lymphocytes were tested in cell-to-cell contact. Lymphocytes were stained with carboxyfluorescein diacetate succinimidyl ester. Inhibition of the proliferation of activated lymphocytes was observed. Following the co-cultivation, the expression of markers involved in the immune response modulation was assessed. Afterwards, an increase in CMSCs expression of IL-10 was detected. Following the co-cultivation with activated lymphocyte, adhesion molecules CD54 and CD44 in the CMSCs increased. An increase of CD54 expression was observed. The properties of CMSCs, adherence and differentiation ability, were confirmed. The phenotype of CMSCs CD105+, CD90+, CD73+, CD44+, CD29+, CD45−, CD34−, CD54+ was characterized. It was demonstrated that chorion-derived MSCs have important immunomodulatory effects.Keywords
Funding Information
- Agentúra na Podporu Výskumu a Vývoja (APVV-17-0278)
- Kultúrna a Edukacná Grantová Agentúra MŠVVaŠ SR (KEGA 023TUKE-4/2020)
- European Regional Development Fund (IMTS 26220220185, ITMS2014+ 313011D103)
- incentives for research and development (S-19-103 / 0001-00)
This publication has 48 references indexed in Scilit:
- Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cellsImmunology & Cell Biology, 2013
- Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem CellsPLOS ONE, 2012
- Mesenchymal stem cell effects on T-cell effector pathwaysStem Cell Research & Therapy, 2011
- MSCs: Biological characteristics, clinical applications and their outstanding concernsAgeing Research Reviews, 2011
- The Use of Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) to Monitor Lymphocyte ProliferationJournal of Visualized Experiments, 2010
- Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for ImmunosuppressionThe Journal of Immunology, 2010
- Mechanism of cellular rejection in transplantationPediatric Nephrology, 2010
- Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T CellsStem Cells, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991